PTK2 and thyroid cancer: Therefore, we hypothesized that the overexpressed PLA2R1 competes with FN1 to bind ITGB1 and inhibit the activation of the downstream FAK-signaling pathway by attenuating the interaction between FN1 and ITGB1, thereby affecting the malignant proliferation of thyroid cancer cells.